Nitroxide pharmaceutical development for age-related degeneration and disease

about

Nitroxides as Antioxidants and Anticancer Drugs.A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta

P2860

Q47121511-C5433C0B-B832-4F1D-ACEB-B7CD06F832B2 Q58697561-E320886B-45EC-45C4-9D34-34CFF8B013DC

P2860

Nitroxide pharmaceutical development for age-related degeneration and disease

Item

http://www.wikidata.org/entity/Q26776523

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Nitroxide pharmaceutical development for age-related degeneration and disease

@ast

Nitroxide pharmaceutical development for age-related degeneration and disease

@en

Nitroxide pharmaceutical development for age-related degeneration and disease

@nl

type

Item

label

Nitroxide pharmaceutical development for age-related degeneration and disease

@ast

Nitroxide pharmaceutical development for age-related degeneration and disease

@en

Nitroxide pharmaceutical development for age-related degeneration and disease

@nl

prefLabel

Nitroxide pharmaceutical development for age-related degeneration and disease

@ast

Nitroxide pharmaceutical development for age-related degeneration and disease

@en

Nitroxide pharmaceutical development for age-related degeneration and disease

@nl

P1476

Nitroxide pharmaceutical development for age-related degeneration and disease

@en

P2093

Albert Tao

http://www.w3.org/2001/XMLSchema#string

Anne K Vallerga

http://www.w3.org/2001/XMLSchema#string

Christopher T Minson

http://www.w3.org/2001/XMLSchema#string

David A Zarling

http://www.w3.org/2001/XMLSchema#string

Jacob A Zarling

http://www.w3.org/2001/XMLSchema#string

Vienna E Brunt

http://www.w3.org/2001/XMLSchema#string

Weixing Li

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Antioxidants, inflammation and cardiovascular disease

Recent developments in the management of dry age-related macular degeneration

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Role of nitric oxide in the vascular effects of local warming of the skin in humans.

Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin.

Decreased nitric oxide- and axon reflex-mediated cutaneous vasodilation with age during local heating.

P304

325

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FGENE.2015.00325

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283981461

http://www.w3.org/2001/XMLSchema#string

P698

26594225

http://www.w3.org/2001/XMLSchema#string

P932

4635221

http://www.w3.org/2001/XMLSchema#string

Nitroxide pharmaceutical development for age-related degeneration and disease

about

P2860

P2860

Nitroxide pharmaceutical development for age-related degeneration and disease

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P5875

P698

P932